Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type (KRAS WT) metastatic colorectal cancer (mCRC) patients (pts).

Authors

Jonathan D Sorah

Jonathan D Sorah

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Jonathan D Sorah , Dominic T. Moore , Matthew Reilley , Mohamed E. Salem , Hanna Kelly Sanoff , Tammy Triglianos , Autumn Jackson McRee , Michael Sangmin Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03446157

DOI

10.1200/JCO.2022.40.4_suppl.088

Abstract #

88

Poster Bd #

E1

Abstract Disclosures